The end of the pandemic is the forecast of the Pfizer manager

“I think life will return to normal in a year’s time,” Bourla said in an interview with ABC’s This Week.

Only that return to normal life will come at a price: “I don’t think that means there will be no new varieties. I don’t think that means we can live without vaccinations. Again, only time will tell. “

Mr Bourla’s insights into when life will finally return to normal are partly in line with those of Stephane Bancel, head of Moderna.

“I think in a year’s time, that would be my guess,” the head of Moderna told the Swiss daily Neue Zuercher Zeitung in response to the question of when we will finally live as before the pandemic.

It will be enough by mid-2022 vaccines doses to vaccinate the entire population, he said. COVID-19 will then become the common flu.

“The pandemic will end in a year,” Bancelis said.

According to him, vaccination against coronavirus could then become part of the combined immunization against respiratory viruses. Moderna has already developed such a vaccine, which is expected to be available from 2023 onwards.

According to the head of “Moderna”, it will soon be possible to vaccinate even babies. “Without vaccination, you will gain immunity in a natural way, because the delta strain is highly contagious. This will put us in a similar situation to the flu. “It will be possible to get vaccinated and have a good winter, or not to get vaccinated and risk getting sick, probably even going to the hospital,” said S. Bancelis.

Coronavir is likely to be vaccinated every year to get life back on track, according to Pfizer chief executive Bourlos.

See also  COVID-19: The pandemic figures in Germany, the United Kingdom, Spain and Italy in the last 24 hours - News

“It seems like the most likely scenario for me, because the virus has spread all over the world, there will only be many varieties. In addition, we have vaccines that are most effective for the year, so an annual booster is the most likely option. Of course, we don’t know exactly yet, we have to wait, and the data will show, “Pfizer’s head said in an interview.

On Friday, Rochelle Walensky, Ph.D., head of the U.S. Centers for Disease Control and Prevention, gave permission to vaccinate high-risk workers with an additional Pfizer and BioNTech vaccine. This decision contradicted the opinion of the Advisory Board.

Mr Walensky also authorized an additional dose of vaccination for older Americans and people with chronic illnesses at least half a year after the first vaccination. This was also endorsed by the Advisory Council.

The World Health Organization opposes vaccination with an additional dose, arguing that richer countries must pass on additional vaccines to countries with the lowest vaccinations.

Mr Bourla said on Sunday that the only criterion for deciding when to approve and when not to accept an additional dose of vaccine was “whether that extra dose is needed”.

On Tuesday, Tom Frieman, a former head of the Centers for Disease Control and Prevention, criticized Moderna and Pfizer for not wanting to share the intellectual property of vaccines widely, thus failing to speed up global vaccination.

“Focusing on selling expensive vaccines to rich countries, Moderna and Pfizer are doing nothing to reduce the supply gap in the vaccine, at least. Shame, ”T. Frieman wrote on Twitter.

See also  Experts warn: The danger of a double pandemic is at the door!

Mr Bourla says sharing intellectual property left and right is not a good idea.

“Intellectual property has helped create a thriving life sciences sector that was ready to withstand an unexpected pandemic blow. If not for her, we wouldn’t be discussing now what to do with the vaccine, because those vaccines wouldn’t be … Plus, we’re very proud of what we did. I can’t understand why Friemann says so. We are very proud. We have saved millions of lives, ”says Bourla.

Pfizer has different financial capabilities to sell its vaccine at a different price. Developing countries buy the vaccine from Pfizer at the expense of the manufacturer, Bourla emphasized, noting that Pfizer sells a billion doses to the U.S. government at cost, and then the U.S. government “transfers the vaccine to the world’s poorest countries free of charge.”

It is strictly forbidden to use the information published by DELFI on other websites, in the media or elsewhere, or to distribute our material in any form without consent, and if consent has been obtained, it is necessary to cite DELFI as the source.

Leave a Comment